Future Market Insights Global and Consulting Pvt. Ltd.
OTC Pain Medication Market to Cross US$ 19 Billion in 2019 as Switch from Rx to Generic OTC Underway
Top Companies Covered in Over-the-Counter Pain Medication Market Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A.,GlaxoSmithKline plc., Bristo-Meyers Squibb and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Merck & o., Cardinal Health Inc.
DUBAI, United Arab Emirates, April 11, 2022 (GLOBE NEWSWIRE) -- The OTC (over-the-counter) pain medication market surpassed US$ 21.8 billion in 2022, with growth influenced by changing perceptions of generic pharmaceutical drugs, according to a recent study published by Future Market Insights (FMI). The study opines that market revenue will rev up at an improved rate of 4.1% to exceed US$ 27.7 Bn in 2028. FMI analyzes various aspects of market growth influencing the OTC pain medication market.
Many consumers are making a shift to generic drugs to reduce total spending on non-prescription or OTC pain medication. Various governing bodies, such as the United States Food and Drug Administration (FDA), have implemented stringent regulations and labeling rules to ensure the safety and effectiveness of OTC pain medications.
Leading players in the OTC pain medication market are collaborating with generic drug-makers to capitalize on the trend of consumer inclination towards generic versions of branded OTC pain medications, finds FMI.
Key Companies Profiled
Pfirzer Inc.
Johnson & Johnson Services Inc.
Bayer AG
Sanofi S.A.
GlaxoSmithKline plc.
Bristo-Meyers Squibb and Company
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Merck & o.
Cardinal Health Inc.
The FMI study features valuable and actionable insights obtained through thorough research on OTC pain medication market. Some of the insights mentioned in the study are,
Growing geriatric population and prevalence of chronic pain-related disorders among the elderly population is bolstering sales of OTC pain medications.
Over 20% of the adult population of the world is already suffering from pain-related disorders and new cased of pain-related problems are reported by over 10% of the global population, which is increasing significantly every years. This is providing an impetus to growth of the OTC pain medication market.
Increasing awareness about the side effects of pain killers, such as stomach ulcers and gastrointestinal problems, may hamper the OTC pain medication market growth.
Developed countries will dominate the OTC pain medications market with more than half the revenue share of the market. However, developing countries in Southeast Asia will witness fastest growth in the OTC pain medication market with rapidly developing pharmaceuticals and healthcare sector in the region.
Acetaminophen Drugs Hold Majority Share in OTC Pain Medication Market
The FMI study thoroughly assesses growth of the OTC pain medication market based on various drug classes, such as Nonsteroidal anti-inflammatory drugs (NSAIDS), acetaminophen, and local anesthetics.
The study finds that acetaminophens are among the most commonly purchased OTC pain medication, and this drug class holds 45% share in the revenues of OTC pain medication market. As acetaminophen is considered as a safer pain medication than other pain relievers, its demand will continue to remain high in the upcoming years, opines the FMI study.
The Consumer Healthcare Products Association (CHPA), an American trade association, recently published a study on the misuse of acetaminophen-based OTC combination products. The study found that a 28 percent decline was recorded in therapeutic misuse exposures involving acetaminophen-containing OTC combination products.
The incidents of acetaminophen misuse decreased from 8,753 to 6,278 between 2007 and 2016, which is a substantial evidence for the safety and effectiveness of acetaminophen-containing OTC pain medications.
Thereby, the FMI study opines that the acetaminophen drugs will maintain a maximum share of over US$ 8.7 billion in the OTC pain medication market through 2019, and the trend will continue to persist in the coming future.
Governments take Initiatives to Spread Awareness about Safe Use of OTC Pain Medications
Despite the increasing reliance on OTC pain medications, a large consumer group is still skeptical about their effectiveness and positive impacts on health. In order to help consumers to avoid incorrect use of OTC pain medications, many governing bodies including FDA have developed guidelines and tips for patients for choosing appropriate OTC pain medications.
Consumers are becoming conscious about the drug fact labeling (DFL) requirements and other regulations vis-à-vis OTC pain medications, which is influencing major dynamics of the OTC pain medication market, projects the FMI study.
The study provides a futuristic overview of the OTC pain medication market with important information about growth prospects of the market during the forecast period 2022-2028. The study predicts that the OTC pain medication market will witness healthy growth at a healthy 4.1% value CAGR to reach US$ 27.7 Bn by the end of the assessment period.
Key Segments of Over-the-Counter Pain Medication Industry Survey
Over-the-Counter Pain Medication Market by Drug Class:
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Local Anaesthetics
Acetaminophen
Over-the-Counter Pain Medication Market by Route of Administration:
Oral
Topical
Others
Over-the-Counter Pain Medication Market by Dosage Form:
Tablets
Capsules
Creams
Gels
Others
Over-the-Mounter Pain Medication Market by Distribution Channel:
Hospital Pharmacies
Drug Stores
Retail Stores
through e-Commerce
Others
Over-the-Counter Pain Medication Market by Region:
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa (MEA)
Have a Look at Related Research Reports:
DNA/RNA Extraction Market – Global DNA/RNA Extraction Market demand is anticipated to grow at a CAGR of 7.7% from 2022 to 2032.
Cystatin C Testing Market – Global Cystatin C Testing Market demand is anticipated to be valued at an impressive rate, expected to exhibit a significantly high CAGR throughout the 2022-2032 forecast period.
Creatine Kinase Reagent Market – Global creatine kinase reagent market demand is anticipated to grow at a CAGR of 6% from 2022 to 2032. The growth of the creatine kinase reagent market is attributed to its global utilization across the healthcare industry.
Immunochemistry Products Market – The immunochemistry products market is anticipated to record a CAGR of 7.25% during the forecast period, up from US$ 2.08 Bn in 2021 to reach a valuation of US$ 4.5 Bn by 2032.
Hemostats for Wound Closure Market – The HemostatsFor Wound Closure Market expected to register a CAGR of 6.3% during the forecast period, up from US$ 2.4 Bn in 2021 to reach a valuation of US$ 3.5 Bn by 2026.
Smart Pill Technologies Market – The smart pill technologies market is projected to record a CAGR of 21% during the forecast period, up from US$ 627.1 Mn in 2020 to reach a valuation of US$ 6176 Mn by 2032.
Virology Market – The virology market is projected to register a CAGR of 5% during the forecast period, up from US$ 2.07 Bn in 2021, to reach a valuation of US$ 3.53 Bn by 2032.
Systemic Lupus Erythematosus (SLE) Drugs Market – The systemic lupus erythematosus (SLE) drugs market is projected to record a CAGR of 5% during the forecast period, up from US$ 183.3 Bn in 2020, to reach a valuation of US$ 329.18 Bn by 2032.
Stem Cell Therapy Market – The stem cell therapy market is expected to grow at a CAGR of 16.7% to USD 401 million by 2026, up from USD 187 million in 2021.
Breath Analyzers Market - The breath analyzers market is projected likely to register a CAGR of 17% during the forecast period, up from US$ 613 Mn in 2021 to reach a valuation of US$ 3.40 Bn by 2032.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centres in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights, Unit No: 1602-006 Jumeirah Bay 2 Plot No: JLT-PH2-X2A Jumeirah Lakes Towers Dubai United Arab Emirates For Sales Enquiries:sales@futuremarketinsights.com
